Hippocampal Atrophy: Causes, Symptoms, and Management

Hippocampal atrophy is the progressive shrinkage of the hippocampus, a curved structure deep in the brain’s temporal lobe that plays a central role in forming new memories and orienting you in space. Some degree of hippocampal volume loss happens with normal aging, but the rate and severity ramp up dramatically in conditions like Alzheimer’s disease, temporal lobe epilepsy, chronic depression, and vascular disease. Understanding what accelerates this shrinkage, how it shows up in daily life, and what can be done about it matters because the hippocampus is one of the few brain regions where interventions have been shown to slow or even partially reverse volume loss.

What the Hippocampus Actually Does

The hippocampus is not a single uniform structure. It contains distinct subregions, each handling slightly different tasks. The CA1 subfield, for instance, is heavily involved in encoding new episodic memories, while the dentate gyrus is one of the rare brain areas where new neurons continue to be born throughout adulthood. The subiculum, at the hippocampus’s output end, helps consolidate memories and transfer them to long-term storage in the cortex. Damage to these subregions produces different cognitive problems, which is why two people with hippocampal atrophy can have noticeably different symptom profiles.

The hippocampus is also unusually sensitive to metabolic insults, stress hormones, and oxygen deprivation. Its neurons are packed with receptors for excitatory neurotransmitters and glucocorticoids, which makes the region powerful at encoding experiences but also vulnerable when those systems go haywire.

Normal Aging Versus Pathological Shrinkage

Everyone’s hippocampus gets a little smaller with age. A large systematic review found that both hippocampal volume and the rate of shrinkage change over time in healthy adults, though these changes are modest compared to what happens in disease states.1PubMed Central. The relationship between hippocampal changes in healthy aging and Alzheimer’s disease: a systematic literature review One study in patients without dementia found that while the hippocampus did get smaller with age in absolute terms, the shrinkage was proportional to overall brain volume loss rather than selective targeting of the hippocampus.2PubMed. Loss of entorhinal cortex and hippocampal volumes compared to whole brain volume in normal aging: the SMART-Medea study In other words, the whole brain was getting slightly smaller, and the hippocampus was simply keeping pace.

Pathological atrophy is different. In Alzheimer’s disease and mild cognitive impairment (MCI), hippocampal shrinkage outpaces the rest of the brain and accelerates over time. The same systematic review noted that hippocampal changes in Alzheimer’s were greater than those in MCI, and changes in MCI were greater than those seen in normal aging.1PubMed Central. The relationship between hippocampal changes in healthy aging and Alzheimer’s disease: a systematic literature review There is also an acceleration effect: in healthy older adults, those who start with smaller hippocampal volumes tend to lose volume faster, suggesting the process can become self-reinforcing.3Frontiers in Aging Neuroscience. Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly

Alzheimer’s Disease and the Amyloid-Tau Cascade

The hippocampus is one of the earliest sites of tau pathology in Alzheimer’s disease, which is why memory problems are usually the first symptom noticed.4NeuroImage: Clinical. Detection of volume loss in hippocampal layers in Alzheimer’s disease using 7 T MRI: A feasibility study But the damage is not evenly spread. High-resolution imaging shows that certain hippocampal layers are hit harder than others, and research using detailed histological analysis confirms that tau tangles cluster in specific subregions rather than blanketing the whole structure. This uneven distribution helps explain why some Alzheimer’s patients lose the ability to form new memories while retaining the ability to recall older ones for a surprisingly long time.

Interestingly, hippocampal volume begins to drop even before tau pathology reaches measurable levels. One study found that hippocampal shrinkage was already detectable during a stage marked by high amyloid burden but no significant tau, suggesting that amyloid itself, or very early inflammatory processes triggered by it, starts chipping away at hippocampal volume before the full neurodegenerative cascade kicks in.5PubMed Central. Associations of hippocampal volumes, brain hypometabolism, and plasma NfL with amyloid, tau, and cognitive decline At the cellular level, multiple death pathways are involved, including inflammation-driven and iron-dependent forms of cell death, which accumulate over years to decades.6PubMed Central. Neuronal cell death mechanisms in Alzheimer’s disease: An insight

Temporal Lobe Epilepsy

Hippocampal sclerosis, a pattern of neuron loss and scarring, is one of the hallmarks of temporal lobe epilepsy. The scarring tends to concentrate in the CA1, CA2, CA3, and hilar subregions, where neurons are replaced by glial cells in a process that stiffens and shrinks the tissue.7PubMed. Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy A meta-analysis of MRI volumetry studies found that the hippocampus on the side of the seizure focus was substantially smaller than in healthy controls, and even the opposite hippocampus showed a smaller but real volume reduction.8PubMed. Hippocampal volume loss in mesial temporal lobe epilepsy: Magnitude and laterality in a meta-analysis of MRI volumetry studies

A complication is that hippocampal sclerosis is not one thing. Different subtypes affect different subfields, and some produce only minimal overall volume changes, which can make them hard to catch on a standard MRI. The specific subtype matters for treatment decisions, including whether epilepsy surgery is likely to be effective, so improved radiological classification is an active area of research.9PubMed Central. Radiologic Classification of Hippocampal Sclerosis in Epilepsy

Chronic Stress, Depression, and the Glucocorticoid Connection

The hippocampus is loaded with receptors for cortisol and other stress hormones, making it a primary target when the body’s stress response stays turned on too long. Animal studies show that prolonged exposure to glucocorticoids causes dendrites in the hippocampus to retract and simplify their branching, reducing the connections between neurons. This dendritic remodeling appears to be at least partially reversible if the stress resolves, distinguishing it from the irreversible cell death seen in neurodegenerative disease.10PubMed Central. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis The same stress hormones that shrink hippocampal neurons cause neurons in the amygdala, the brain’s fear center, to grow and branch out, which may explain why chronic stress simultaneously worsens memory and increases anxiety.11PubMed. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain

In humans, the link between depression and smaller hippocampal volume is well established. A meta-analysis found that depressed patients have measurably lower hippocampal volume compared to people without depression.12PubMed. Lower hippocampal volume in patients suffering from depression: a meta-analysis A large study of nearly 2,000 adults showed that the relationship between depressive symptoms and hippocampal volume was strongest in people with at least moderate symptom severity and became more pronounced with age.13Neuropsychopharmacology. Association of Depressive Symptoms with Hippocampal Volume in 1936 Adults PTSD and traumatic brain injury add to this picture: higher anxiety symptoms in the months following a moderate-to-severe brain injury predicted greater hippocampal volume loss over the following year, particularly in the right hippocampus.14PubMed. Higher Anxiety Symptoms Predict Progressive Hippocampal Atrophy in the Chronic Stages of Moderate to Severe Traumatic Brain Injury

Vascular Disease and Diabetes

Poor blood flow to the brain takes a toll on the hippocampus, even when it does not cause an obvious stroke. In subcortical ischemic vascular disease, the severity of cognitive impairment correlated more strongly with hippocampal and cortical gray matter atrophy than with the number or size of small vessel strokes themselves.15PubMed Central. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease At the microscopic level, pericytes, the cells that wrap around and support tiny blood vessels, are reduced by roughly a quarter to almost half in the hippocampal CA1 region in people with vascular dementia and Alzheimer’s disease. Those pericyte losses correlated with CA1 volume shrinkage.16PubMed Central. Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion

Type 2 diabetes is another vascular-metabolic risk factor. A population-based study found that people with type 2 diabetes had significantly smaller volumes across multiple hippocampal subfields compared to people with normal blood sugar. Even prediabetes showed a trend in the same direction when researchers looked at continuous measures of blood sugar control, suggesting that chronically elevated glucose harms the hippocampus in a dose-dependent way.17PubMed Central. The association of prediabetes and type 2 diabetes with hippocampal subfields volume: The Maastricht study

Heavy alcohol use compounds these risks. Patients with alcohol use disorder showed significant hippocampal volume loss, and the type of alcohol consumed appeared to influence the degree of shrinkage, with the wine group showing the smallest volumes and the spirits group falling in between.18PubMed. Hippocampal volume loss in patients with alcoholism is influenced by the consumed type of alcoholic beverage The reasons for beverage-specific differences are not fully understood and may involve confounding drinking patterns, but the overall message is clear: chronic heavy drinking is bad for the hippocampus.

How Hippocampal Atrophy Shows Up in Daily Life

The most characteristic symptom is difficulty forming new memories. You can carry on a conversation, recall childhood stories, and recognize people you know, but you keep forgetting where you put your keys, what you had for breakfast, or what someone just told you. This pattern, where new learning is impaired while older memories are relatively preserved, reflects the hippocampus’s role as a gateway for new information rather than a long-term storage vault.

Specific subregion damage maps onto specific deficits. In people with multiple sclerosis, for example, damage to the CA1 and subiculum correlated with poorer performance on memory and visuospatial tests, while other hippocampal subregions were relatively spared.19PubMed. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS Separately, the posterior part of the subiculum has been shown to be particularly tied to recall performance: people with smaller posterior subiculum volumes forgot more items on a delayed word-recall test, even if they did not meet criteria for dementia.20Frontiers in Aging Neuroscience. Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals

Beyond memory, hippocampal atrophy can contribute to spatial disorientation, trouble navigating familiar routes, and difficulty imagining future scenarios, since the hippocampus helps with mental simulation of both past and future events. Mood changes are also common, given the strong bidirectional connection between the hippocampus and emotion-regulating circuits.

How Doctors Detect and Measure It

Structural MRI is the standard tool. A trained radiologist can visually assess hippocampal size and shape, and automated software can compute precise volumes by segmenting the hippocampus from surrounding tissue. Newer deep-learning-based segmentation tools have outperformed older automated methods in detecting hippocampal sclerosis, with one study finding that deep-learning segmentation produced larger effect sizes and better classification accuracy than traditional software.21PubMed Central. A Quantitative Imaging Biomarker Supporting Radiological Assessment of Hippocampal Sclerosis Derived From Deep Learning-Based Segmentation of T1w-MRI

Quantitative reports that overlay volume data onto a standard MRI have also improved diagnostic accuracy. When radiologists and image analysts received these automated quantitative reports alongside standard scans, their accuracy in identifying hippocampal sclerosis improved, particularly for tricky bilateral cases where both hippocampi are affected and there is no obvious side-to-side asymmetry to catch the eye.22PubMed Central. Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis

Volume alone may not tell the whole story. Research comparing hippocampal texture (a measure of the internal structural pattern visible on MRI) against simple volume measurements found that texture was a better predictor of which people with mild cognitive impairment would progress to Alzheimer’s disease. The texture marker remained significant even after accounting for volume, suggesting it captures microstructural damage that pure size measurements miss.23PubMed Central. Early detection of Alzheimer’s disease using MRI hippocampal texture Asymmetry between left and right hippocampal volumes may also serve as a marker, since the normal slight right-greater-than-left asymmetry appears to flatten or reverse in MCI and Alzheimer’s disease.24Scientific Reports. Evaluation of deep learning models for segmentation of hippocampus volumes from MRI images in Alzheimer’s disease

Exercise and Hippocampal Volume

If there is a single intervention with the strongest evidence for protecting hippocampal volume, it is aerobic exercise. A randomized controlled trial of 120 older adults found that a year of moderate aerobic exercise increased the size of the anterior hippocampus by about two percent, effectively reversing one to two years of normal age-related shrinkage. The control group, which did only stretching, lost about one to one and a half percent of hippocampal volume over the same period. The volume gains were associated with higher blood levels of brain-derived neurotrophic factor (BDNF), a protein that supports the growth and survival of new neurons.25PubMed Central. Exercise training increases size of hippocampus and improves memory Both animal and human studies confirm that aerobic exercise upregulates BDNF expression specifically in the hippocampus, promoting neurogenesis in the dentate gyrus.26Frontiers in Neuroscience. Exercise-Mediated Neurogenesis in the Hippocampus via BDNF

The practical takeaway here is straightforward. Walking briskly for about 40 minutes a few times a week was enough to produce these effects. You do not need extreme endurance training. The gains were meaningful both structurally and functionally, as participants in the exercise group also improved on spatial memory tasks.

Medications That Target Atrophy

Drug options for directly slowing hippocampal shrinkage are limited, but some evidence exists. A meta-analysis of acetylcholinesterase inhibitors, the class of drugs most commonly prescribed for Alzheimer’s, found that donepezil at a higher dose significantly slowed hippocampal atrophy compared to placebo. The lower dose did not show a meaningful effect, suggesting there is a dose threshold for neuroprotection. In patients with MCI, both donepezil and vitamin E were associated with reduced hippocampal shrinkage. Another drug in the same class, galantamine, did not significantly slow hippocampal atrophy overall, though it did reduce whole-brain atrophy in carriers of the APOE ε4 gene variant.27PubMed Central. Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis An earlier study of donepezil-treated Alzheimer’s patients reported an average annual hippocampal volume loss of about 3.8 percent, compared to roughly 5 percent in untreated patients.28PubMed. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer’s disease?

For depression-related hippocampal changes, antidepressants may offer some neuroprotection. Evidence suggests that treating depression can guard against hippocampal volume loss that accumulates with repeated depressive episodes, potentially breaking the cycle of stress-driven shrinkage.29Translational Psychiatry. Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease This is not a case of antidepressants growing the hippocampus back. It is more about preventing further erosion by keeping depression under control.

Cognitive Reserve and Why Two People With the Same Shrinkage Can Function Differently

One of the more fascinating findings in this field is that hippocampal atrophy does not doom everyone equally. Some people maintain surprisingly good memory and daily function despite measurable hippocampal shrinkage, a phenomenon attributed to cognitive reserve. Neuroimaging research has found that people who maintain good memory despite hippocampal atrophy tend to recruit additional temporal lobe regions during memory tasks, essentially compensating with backup circuitry.30PubMed Central. Neural correlates of resilience to the effects of hippocampal atrophy on memory

Cognitive reserve appears to buffer more than just memory. A recent preprint study found that among people with smaller hippocampal volumes, those with higher cognitive reserve scores were significantly less likely to develop neuropsychiatric symptoms like apathy, irritability, and agitation. The protective effect was not present in the low-reserve group.31bioRxiv. Cognitive reserve as a moderator of the association between brain structure and later-life behavioural symptoms across the neurocognitive spectrum Factors that build cognitive reserve, such as years of education, occupational complexity, social engagement, and lifelong intellectual activity, do not undo hippocampal damage. They create redundancy in brain networks so that when one hub weakens, others can pick up the slack.

Noninvasive Brain Stimulation

Because the hippocampus sits deep inside the brain, it cannot be reached directly with external brain stimulation techniques. But it is tightly connected to a region on the parietal cortex that can be reached. Researchers have exploited this anatomical link using transcranial magnetic stimulation (TMS) aimed at the parietal spot most strongly connected to each individual’s hippocampus. A recent study using intracranial electrodes confirmed that parietal TMS guided by functional connectivity mapping successfully drove hippocampal activity, boosting hippocampal theta rhythms, a brainwave pattern closely tied to memory encoding. Repeated sessions of this targeted stimulation suppressed abnormal theta activity in hippocampal contacts with large effect sizes.32Nature Communications. Multimodal evidence for hippocampal engagement and modulation by functional connectivity-guided parietal TMS Whether this translates into clinically meaningful improvements in memory or slowing of atrophy over the long term is still being tested, but the ability to noninvasively modulate deep hippocampal circuits is a significant step.

The Gut Microbiome and Hippocampal Health

An increasingly active research frontier connects the gut microbiome to hippocampal function. The gut and brain communicate through several channels: the vagus nerve, immune signaling molecules, and metabolites produced by gut bacteria. When the gut microbiome becomes imbalanced, bacterial products can increase the permeability of both the intestinal barrier and the blood-brain barrier, allowing inflammatory molecules to reach the hippocampus and interfere with neurogenesis and synaptic plasticity.33Frontiers in Cellular and Infection Microbiology. Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors

Animal studies show that manipulating the microbiome through diet, prebiotics, probiotics, or antibiotics can influence neural stem cell activity in hippocampal neurogenic zones.34PubMed Central. The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes Natural dietary compounds with anti-inflammatory properties, such as polyphenols and omega-3 fatty acids, may exert their brain-protective effects partly through changes in the gut flora.35PubMed Central. Microbiota-Gut-Brain Axis Regulation of Adult Hippocampal Neurogenesis Most of this evidence comes from animal research, and direct proof in humans is still thin. But the gut microbiome is far easier to modify than the brain itself, which makes it an attractive therapeutic target for future interventions aimed at supporting hippocampal health. A Mediterranean-style diet rich in fiber, fermented foods, and healthy fats checks many of these boxes simultaneously, even if the exact mechanisms are not yet nailed down.